Compare Capex To Revenue Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Capex To Revenue Analysis
Compare CytomX Therapeutics, Spero Therapeutics, and Neoleukin Therapeutics Capex To Revenue Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTMX | 0.8243 | 0.8243 | 0.8243 | 0.8243 | 0.3276 | 0.2067 | 0.1447 | 0.0218 | 0.0637 | 0.0608 | 0.023 | 0.0231 | 0.0327 | 0.0083 | 0.0079 |
SPRO | 2.4776 | 2.4776 | 2.4776 | 2.4776 | 2.4776 | 2.4776 | 2.4776 | 0.0136 | 0.6142 | 0.0662 | 0.0168 | 0.0021 | 0.0021 | 0.0025 | 0.0023 |
TIL | 368 | 368 | 368 | 368 | 368 | 368 | 368 | 368 | 368 | 368 | 368 | 368 | 368 | 331 | 295 |
ASMB | 0.0959 | 0.0959 | 0.0959 | 0.0959 | 0.0959 | 0.0959 | 0.0959 | 0.0959 | 0.023 | 0.0974 | 0.0281 | 0.495 | 0.0356 | 0.032 | 0.0304 |
NUVB | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ACHL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
CytomX Therapeutics, Spero Therapeutics, and Neoleukin Therapeutics Capex To Revenue description
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Gambling Invested over 90 shares | ||
Macroaxis Index Invested few shares | ||
Warren Buffett Holdings Invested over 60 shares | ||
Impulse Invested over 100 shares | ||
Banking Invested over 20 shares | ||
Baby Boomer Prospects Invested over 40 shares | ||
SRI Sustainable Growth Invested few shares | ||
Investor Favorites Invested few shares | ||
Automobiles and Trucks Invested over 50 shares | ||
Chemicals Invested over 30 shares | ||
Macroaxis Picks Invested over 30 shares | ||
FinTech Invested over 60 shares | ||
Hedge Favorites Invested few shares |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |